Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: Comparison with NK1 and NK3 binding sites

Neuroscience

Volumn 116, Issue 3, 2003, Pages 761-773

  Saffroy, M ^a   Torrens, Y ^a   Glowinski, J ^a   Beaujouan, J C ^a  

^a l'alimentation et l'Environnement   (France)

Author keywords

(2 125I iodohistidyl1)neurokinin A, NK1, NK2, and NK3 binding sites; Autoradiographic localization; Central tachykinin receptors

Indexed keywords

ELEDOISIN; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; NEUROKININ A; NEUROPEPTIDE GAMMA; NEUROPEPTIDE K; NOLPITANTIUM; SAREDUTANT; SENKTIDE; SUBSTANCE P;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; BRAIN FUNCTION; BRAIN MEMBRANE; BRAIN REGION; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SEPTUM PELLUCIDUM; THALAMUS;

EID: 0037450507     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00748-0     Document Type: Article

References (63)

1. Arai H., Emson P.C. Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system. Brain Res. 399:1986;240-249.
2. Beaujouan J.C., Saffroy M., Torrens Y., Glowinski J. Different subtypes of tachykinin NK(1) receptor binding sites are present in the rat brain. J Neurochem. 75:2000;1015-1026.
3. Beaujouan J.C., Torrens Y., Saffroy M., Glowinski J. Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain. Neuroscience. 18:1986;857-875.
4. Beaujouan J.C., Torrens Y., Viger A., Glowinski J. A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative. Mol Pharmacol. 26:1984;248-254.
5. Bensaid M., Faucheux B.A., Hirsch E., Agid Y., Soubrie P., Oury-Donat F. Expression of tachykinin NK2 receptor mRNA in human brain. Neurosci Lett. 303:2001;25-28.
6. Bucinskaite V., Brodda-Jansen G., Stenfors C., Theodorsson E., Lundeberg T. Increased concentrations of calcitonin gene-related peptide-like immunoreactivity in rat brain and peripheral tissue after ischaemia correlation to flap survival . Neuropeptides. 32:1998;179-183.
7. Buck S.H., Helke C.J., Burcher E., Shults C.W., O'Donohue T.L. Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system. Peptides. 7:1986;1109-1120.
8. Dam T.V., Escher E., Quirion R. Evidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex. Brain Res. 453:1988;372-376.
9. Dam T.V., Takeda Y., Krause J.E., Escher E., Quirion R. gamma-Preprotachykinin-(72-92)-peptide amide an endogenous preprotachykinin I gene-derived peptide that preferentially binds to neurokinin-2 receptors . Proc Natl Acad Sci USA. 87:1990;246-250.
10. Diez-Guerra F.J., Sirinathsinghji D.J., Emson P.C. In vitro and in vivo release of neurokinin A-like immunoreactivity from rat substantia nigra. Neuroscience. 27:1988;527-536.
11. Emonds-Alt X., Advenier C., Cognon C., Croci T., Daoui S., Ducoux J.P., Landi M., Naline E., Neliat G., Poncelet M., Proietto V., Van Broeck D., Vilain P., Soubrie P., Le Fur G., Maffrand J.P., Breliere J.C. Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist. Neuropeptides. 31:1997;449-458.
12. Gerfen C.R., Young W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments an in situ hybridization histochemistry and fluorescent retrograde tracing study . Brain Res. 460:1988;161-167.
13. Griebel G. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? Pharmacol Ther. 82:1999;1-61.
14. Griebel G., Moindrot N., Aliaga C., Simiand J., Soubrie P. Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery. Neurosci Biobehav Rev. 25:2001;619-626.
15. Guard S., Watson S.P. Tachykinin receptor types classification and membrane signalling mechanisms . Neurochem Int. 18:1991;149-165.
16. Hagan R.M., Beresford I.J., Stables J., Dupere J., Stubbs C.M., Elliott P.J., Sheldrick R.L., Chollet A., Kawashima E., McElroy A.B., Ward P. Characterisation, CNS distribution and function of NK2 receptors studied using potent NK2 receptor antagonists. Regul Pept. 46:1993;9-19.
17. Kemel M.L., Perez S., Godeheu G., Soubrie P., Glowinski J. Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum. J Neurosci. 22:2002;1929-1936.
18. Kramer M.S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J.J., Reines S.A., Liu G., Snavely D., Wyatt-Knowles E., Hale J.J., Mills S.G., MacCoss M., Swain C.J., Harrison T., Hill R.G., Hefti F., Scolnick E.M., Cascieri M.A., Chicchi G.G., Sadowski S., Williams A.R., Hewson L., Smith D., Rupniak N.M., et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 281:1998;1640-1645.
19. Krause J.E., MacDonald M.R., Takeda Y. The polyprotein nature of substance P precursors. Bioessays. 10:1989;62-69.
20. Langlois X., Wintmolders C., te Riele P., Leysen J.E., Jurzak M. Detailed distribution of neurokinin 3 receptors in the rat, guinea pig and gerbil brain a comparative autoradiographic study . Neuropharmacology. 40:2001;242-253.
21. Lesch K.P. Mouse anxiety the power of knockout . Pharmacogenom J. 1:2001;187-192.
22. Lessard A., Couture R. Modulation of cardiac activity by tachykinins in the rat substantia nigra. Br J Pharmacol. 134:2001;1749-1759.
23. Lindefors N., Brodin E., Ungerstedt U. Neuroleptic treatment induces region-specific changes in levels of neurokinin A and substance P in rat brain. Neuropeptides. 7:1986;265-280.
24. Lindefors N., Brodin E., Ungerstedt U. Amphetamine facilitates the in vivo release of neurokinin A in the nucleus accumbens of the rat. Eur J Pharmacol. 160:1989;417-420.
25. Liu H., Brown J.L., Jasmin L., Maggio J.E., Vigna S.R., Mantyh P.W., Basbaum A.I. Synaptic relationship between substance P and the substance P receptor light and electron microscopic characterization of the mismatch between neuropeptides and their receptors . Proc Natl Acad Sci USA. 91:1994;1009-1013.
26. Maggi C.A. Principles of tachykininergic co-transmission in the peripheral and enteric nervous system. Regul Pept. 93:2000;53-64.
27. Maggi C.A., Schwartz T.W. The dual nature of the tachykinin NK1 receptor. Trends Pharmacol Sci. 18:1997;351-355.
28. Mantyh P.W., Gates T., Mantyh C.R., Maggio J.E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci. 9:1989;258-279.
29. Marcus M.M., Nomikos G.G., Malmerfelt A., Zachrisson O., Lindefors N., Svensson T.H. Effect of chronic antipsychotic drug treatment on preprosomatostatin and preprotachykinin A mRNA levels in the medial prefrontal cortex, the nucleus accumbens and the caudate putamen of the rat. Brain Res Mol Brain Res. 45:1997;275-282.
30. Martini-Luccarini F., Reynaud J.C., Puizillout J.J. Effects of tachykinins on identified dorsal vagal neurons an electrophysiological study in vitro . Neuroscience. 71:1996;119-131.
31. Maubach K.A., Jones R.S. Electrophysiological characterisation of tachykinin receptors in the rat nucleus of the solitary tract and dorsal motor nucleus of the vagus in vitro. Br J. Pharmacol. 122:1997;1151-1159.
32. Mazzone S.B., Geraghty D.P. Characterization and regulation of tachykinin receptors in the nucleus tractus solitarius. Clin Exp Pharmacol Physiol. 27:2000;939-942.
33. Mileusnic D., Lee J.M., Magnuson D.J., Hejna M.J., Krause J.E., Lorens J.B., Lorens S.A. Neurokinin-3 receptor distribution in rat and human brain an immunohistochemical study . Neuroscience. 89:1999;1269-1290.
34. Mussap C.J., Geraghty D.P., Burcher E. Tachykinin receptors a radioligand binding perspective . J Neurochem. 60:1993;1987-2009.
35. Palanche T., Ilien B., Zoffmann S., Reck M.P., Bucher B., Edelstein S.J., Galzi J.L. The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. J Biol Chem. 276:2001;34853-34861.
36. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1997;Academic Press, New York.
37. Petitet F., Beaujouan J.C., Saffroy M., Torrens Y., Chassaing G., Lavielle S., Besseyre J., Garret C., Carruette A., Glowinski J. Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors. J Neurochem. 56:1991;879-889.
38. Petitet F., Saffroy M., Torrens Y., Lavielle S., Chassaing G., Loeuillet D., Glowinski J., Beaujouan J.C. Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Peptides. 13:1992;383-388.
39. Picard P., Regoli D., Couture R. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat characterization of receptors with selective antagonists . Br J Pharmacol. 112:1994;240-249.
40. Pickel V.M., Douglas J., Chan J., Gamp P.D., Bunnett N.W. Neurokinin 1 receptor distribution in cholinergic neurons and targets of substance P terminals in the rat nucleus accumbens. J Comp Neurol. 423:2000;500-511.
41. Polidori C., Ciccocioppo R., De Caro G., Massi M. Further evidence that central tachykinin NK-1 receptors mediate the inhibitory effect of tachykinins on angiotensin-induced drinking in rats. Peptides. 19:1998;149-155.
42. Quirion R., Dam T.V., Guard S. Selective neurokinin receptor radioligands. Ann NY Acad Sci. 632:1991;137-144.
43. Saffroy M., Beaujouan J.C., Torrens Y., Besseyre J., Bergström L., Glowinski J. Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain. Peptides. 9:1988;227-241.
44. Saffroy M., Torrens Y., Glowinski J., Beaujouan J.C. Presence of NK2 binding sites in the rat brain. J Neurochem. 79:2001;985-996.
45. Shults C.W., Johnston P., Gage F.H. Comparison of substance K-like and substance P-like fibers and cells in the rat hippocampus. Brain Res. 426:1987;290-296.
46. Shults C.W., Quirion R., Chronwall B., Chase T.N., O'Donohue T.L. A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system. Peptides. 5:1984;1097-1128.
47. Sperk G., Marksteiner J., Saria A., Humpel C. Differential changes in tachykinins after kainic acid-induced seizures in the rat. Neuroscience. 34:1990;219-224.
48. Steinberg R., Alonso R., Griebel G., Bert L., Jung M., Oury-Donat F., Poncelet M., Gueudet C., Desvignes C., Le Fur G., Soubrie P. Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function. J Pharmacol Exp Ther. 299:2001;449-458.
49. Steinberg R., Marco N., Voutsinos B., Bensaid M., Rodier D., Souilhac J., Alonso R., Oury-Donat F., Le Fur G., Soubrie P. Expression and presence of septal neurokinin-2 receptors controlling hippocampal acetylcholine release during sensory stimulation in rat. Eur J Neurosci. 10:1998;2337-2345.
50. Steinberg R., Souilhac J., Rodier D., Alonso R., Emonds-Alt X., Le Fur G., Soubrie P. Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation involvement of enhanced nitric oxide production via neurokinin-2 receptor activation . Neuroscience. 84:1998;511-518.
51. Stoessl A.J., Hill D.R. Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktide. Brain Res. 534:1990;1-7.
52. 3H]SR48968. Br J Pharmacol. 117:1996;295P.
53. Stumm R., Culmsee C., Schafer M.K., Krieglstein J., Weihe E. Adaptive plasticity in tachykinin and tachykinin receptor expression after focal cerebral ischemia is differentially linked to gabaergic and glutamatergic cerebrocortical circuits and cerebrovenular endothelium. J Neurosci. 21:2001;798-811.
54. Takeda Y., Takeda J., Smart B.M., Krause J.E. Regional distribution of neuropeptide gamma and other tachykinin peptides derived from the substance P gene in the rat. Regul Pept. 28:1990;323-333.
55. Tooney P.A., Crawter V.C., Chahl L.A. Increased tachykinin NK(1) receptor immunoreactivity in the prefrontal cortex in schizophrenia. Biol Psychiatry. 49:2001;523-527.
56. Toru M., Watanabe S., Shibuya H., Nishikawa T., Noda K., Mitsushio H., Ichikawa H., Kurumaji A., Takashima M., Mataga N. Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr Scand. 78:1988;121-137.
57. Tremblay L., Kemel M.L., Desban M., Gauchy C., Glowinski J. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors. Proc Natl Acad Sci USA. 89:1992;11214-11218.
58. Valentino K.L., Tatemoto K., Hunter J., Barchas J.D. Distribution of neuropeptide K-immunoreactivity in the rat central nervous system. Peptides. 7:1986;1043-1059.
59. Van den Bos R., Cools A.R., Ogren S.O. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat. Acta Physiol Scand. 138:1990;423-424.
60. Viger A., Beaujouan J.C., Torrens Y., Glowinski J. Specific binding of a 125I-substance P derivative to rat brain synaptosomes. J Neurochem. 40:1983;1030-1039.
61. Vollmer J.Y., Alix P., Chollet A., Takeda K., Galzi J.L. Subcellular compartmentalization of activation and desensitization of responses mediated by NK2 neurokinin receptors. J Biol Chem. 274:1999;37915-37922.
62. Watling K.J., Guard S., Krause J.E., Takeda Y., Quirion R., Zarnegar R., Pain D., Franks R. On the presence of NK2 receptor subtypes in peripheral and central tissues. Regul Pept. 46:1993;311-313.
63. Zachrisson O., Lindefors N., Brene S. A tachykinin NK1 receptor antagonist, CP-122, 721-1, attenuates kainic acid-induced seizure activity. Brain Res Mol Brain Res. 60:1998;291-295.